Nifty
Sensex
:
:
25571.25
82814.71
116.90 (0.46%)
316.57 (0.38%)

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 532516 | NSE: SURYAPHARM

Not traded in the last 30 days
  • Open
  • High
  • Low
  • Previous Close
  •  N/A
  •  N/A
  •  N/A
  •  N/A
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  N/A
  •  N/A
  •  N/A
  •  N/A

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 3.24
  • N/A
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,166.28
  • N/A
  • N/A

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 0.96%
  • 19.20%
  • 76.64%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 3.20%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone /

Consolidated
Description
Mar 13
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
-3.25
9.19
23.17
19.07
ROA
-16.34%
-13.83%
5.10%
5.30%
ROE
-451.80%
-82.55%
22.91%
24.85%
ROCE
-12.70%
-11.96%
15.35%
14.74%
Fixed Asset Turnover
0.10
2.39
3.89
3.61
Receivable days
917.33
56.73
49.48
48.61
Inventory Days
2833.48
193.63
185.68
207.56
Payable days
71.77
15.89
43.65
98.52
Cash Conversion Cycle
3679.04
234.46
191.52
157.64
Total Debt/Equity
-26.89
8.32
2.89
2.40
Interest Cover
-1.21
-1.32
2.13
2.41

Annual Reports:

News Update:


No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.